Steven Hass

4.2k total citations · 1 hit paper
65 papers, 3.1k citations indexed

About

Steven Hass is a scholar working on General Health Professions, Epidemiology and Genetics. According to data from OpenAlex, Steven Hass has authored 65 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in General Health Professions, 13 papers in Epidemiology and 13 papers in Genetics. Recurrent topics in Steven Hass's work include Inflammatory Bowel Disease (13 papers), Food Allergy and Anaphylaxis Research (10 papers) and Microscopic Colitis (9 papers). Steven Hass is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Food Allergy and Anaphylaxis Research (10 papers) and Microscopic Colitis (9 papers). Steven Hass collaborates with scholars based in United States, United Kingdom and France. Steven Hass's co-authors include Clayton R. Rowland, Mark J. Atkinson, Shoshana Colman, Meryl Brod, Ritesh Kumar, Joseph C. Cappelleri, F. Reed Johnson, Semra Özdemir, William J. Sandborn and David W. Miller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Neurology.

In The Last Decade

Steven Hass

62 papers receiving 3.0k citations

Hit Papers

Validation of a general measure of treatment satisfaction... 2004 2026 2011 2018 2004 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.
    2004 747 citations Mark J. Atkinson, Steven Hass et al. Health and Quality of Life Outcomes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Hass United States 24 567 461 417 404 345 65 3.1k
Kathleen Beusterien United States 31 445 0.8× 256 0.6× 423 1.0× 185 0.5× 508 1.5× 101 3.2k
C. Acquadro France 18 323 0.6× 526 1.1× 393 0.9× 246 0.6× 278 0.8× 57 2.6k
Margaret C. Reilly United States 17 544 1.0× 704 1.5× 364 0.9× 184 0.5× 512 1.5× 34 3.6k
Donald M. Bushnell United States 28 381 0.7× 466 1.0× 321 0.8× 348 0.9× 315 0.9× 81 3.2k
Elizabeth Molsen United States 8 279 0.5× 346 0.8× 446 1.1× 180 0.4× 262 0.8× 8 2.6k
Catherine Meads United Kingdom 39 665 1.2× 504 1.1× 294 0.7× 304 0.8× 228 0.7× 143 5.3k
Lena Ring Sweden 26 328 0.6× 739 1.6× 460 1.1× 259 0.6× 307 0.9× 53 3.6k
Mariam Vahdaninia Iran 23 425 0.7× 667 1.4× 154 0.4× 580 1.4× 380 1.1× 38 3.3k
Julio López‐Bastida Spain 31 249 0.4× 385 0.8× 611 1.5× 209 0.5× 278 0.8× 76 2.5k
Eunice Chang United States 31 530 0.9× 209 0.5× 173 0.4× 192 0.5× 550 1.6× 161 4.3k

Countries citing papers authored by Steven Hass

Since Specialization
Citations

This map shows the geographic impact of Steven Hass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Hass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Hass more than expected).

Fields of papers citing papers by Steven Hass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Hass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Hass. The network helps show where Steven Hass may publish in the future.

Co-authorship network of co-authors of Steven Hass

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Hass. A scholar is included among the top collaborators of Steven Hass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Hass. Steven Hass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, Silke, Steven Hass, Anne Chocat, et al.. (2024). Circulating Stress Hormones, Brain Health, and Cognition in Healthy Older Adults: Cross-Sectional Findings and Sex Differences in Age-Well. SHILAP Revista de lepidopterología. 5(2). 100431–100431.
2.
3.
Hung, Anna, Juan Marcos González, Jui‐Chen Yang, et al.. (2021). Heterogeneity in Parent Preferences for Peanut Desensitization Therapy. The Journal of Allergy and Clinical Immunology In Practice. 9(9). 3459–3465. 3 indexed citations
4.
Nowak‐Węgrzyn, Anna, Steven Hass, Sarah M. Donelson, et al.. (2021). The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers. World Allergy Organization Journal. 14(2). 100512–100512. 40 indexed citations
5.
Yu, Shengsheng, Steven Hass, Eric Q. Wu, et al.. (2021). The Risk Reduction of Accidental Exposure-Related Systemic Allergic Reactions Extrapolated Based on Food Challenge Data After 1 Year of Peanut Oral Immunotherapy. Advances in Therapy. 38(8). 4321–4332. 1 indexed citations
6.
Märshall, Thomas, Amy Pugh, Angelyn Fairchild, & Steven Hass. (2017). Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease. Value in Health. 20(10). 1383–1393. 27 indexed citations
7.
8.
Freedman, Mark S., Xavier Montalbán, Aaron E. Miller, et al.. (2016). Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis. Multiple Sclerosis and Related Disorders. 10. 204–212. 24 indexed citations
9.
Tundia, Namita, et al.. (2015). Validation and u.s. Population norms of health-related productivity questionnaire. Value in Health. 18(3). A24–A24. 14 indexed citations
10.
Vollmer, Timothy, Eva Havrdová, Krzysztof Selmaj, et al.. (2013). Daclizumab High-Yield Process Treatment Reduced the Impact of Multiple Sclerosis Relapse on Health-Related Quality of Life (Results of the SELECT Trial) (P03.212). Neurology. 80(7_supplement). 1 indexed citations
11.
Fernandez, Hubert H., Arvydas Vanagunas, Per Odin, et al.. (2013). Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results. Parkinsonism & Related Disorders. 19(3). 339–345. 73 indexed citations
12.
Tundia, Namita, Menaka Bhor, Amy Duhig, et al.. (2012). PMH58 Impact of Positive and Negative Symptoms and Cognitive Impairment on Health Outcomes and Healt Care Resource Utilization in European Patients with Schizophrenia. Value in Health. 15(4). A92–A92. 1 indexed citations
13.
Arrighi, H. Michael, et al.. (2009). Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease. The American Journal of Gastroenterology. 104(10). 2524–2533. 161 indexed citations
14.
Johnson, F. Reed, George Van Houtven, Semra Özdemir, et al.. (2009). Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy. Journal of Neurology. 256(4). 554–562. 104 indexed citations
15.
Sands, Bruce E., et al.. (2007). Gastroenterologists’ Tolerance for Crohnʼs Disease Treatment Risks. The American Journal of Gastroenterology. 102. S492–S492. 2 indexed citations
16.
Atkinson, Mark J., et al.. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.. Health and Quality of Life Outcomes. 2(1). 12–12. 747 indexed citations breakdown →
17.
Leibson, C. L., Tingjun Hu, Robert D. Brown, et al.. (1996). Utilization of acute care services in the year before and after first stroke: A population-based study.. PubMed. 46(3). 861–9. 94 indexed citations
18.
Smith, Dean G., et al.. (1996). A Cost Analysis of Alprostadil in Liver Transplantation. PharmacoEconomics. 9(6). 517–524. 10 indexed citations
19.
Hass, Steven & Michael J. Lucas. (1994). Net Economic Benefit of a Manufactured Dinoprostone Gel for Pre-Induction Cervical Ripening. PharmacoEconomics. 5(1). 39–47. 3 indexed citations
20.
Hass, Steven, et al.. (1992). Medicaid Drug Utilisation Review Under OBRA 1990. PharmacoEconomics. 2(5). 363–370. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Beusterien Breakdown of academic impact, for papers by C. Acquadro Breakdown of academic impact, for papers by Margaret C. Reilly Breakdown of academic impact, for papers by Donald M. Bushnell Breakdown of academic impact, for papers by Elizabeth Molsen Breakdown of academic impact, for papers by Catherine Meads Breakdown of academic impact, for papers by Lena Ring Breakdown of academic impact, for papers by Mariam Vahdaninia Breakdown of academic impact, for papers by Julio López‐Bastida Breakdown of academic impact, for papers by Eunice Chang
Rankless by CCL
2026